Responses
J: Clinical therapeutics
J10 Analysis of integrated safety data from pridopidine clinical trials demonstrates a favorable safety and tolerability profile at the clinically relevant dose of 45 mg bid
Compose a Response to This Article
Other responses
No responses have been published for this article.